Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Beacon Pharmaceuticals |
Iron Sucrose 100mg/15ml |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Sanofi |
Furosemide and amiloride 5mg |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Himmel Pharma |
|
Product Type |
Product Size |
Drops |
1'S |
Product Company |
ICI Pakistan |
Nystatin 50ml |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Fresenius kabi |
Cytarabine 500mg/50ml |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Himmel Pharma |
|
Content | Xenofer is a dietary supplement containing high quality ingredients essential for prevention of iron deficiency. | A combination of Furosemide and Amiloride is a diuretic which reduces the potassium loss of furosemide alone while avoiding the possible gastro-intestinal disturbances of potassium supplements.
| Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Nystatin is an antifungal medicine and not an antibiotic. It makes holes in the cell membrane of the fungus and the contents leak out. This kills the fungus and treats the infection. If you're taking nystatin to prevent an infection, the medicine kills any fungus as it starts to appear.
| Cytarabine is a medication used in the management and treatment of leukemias and lymphomas. It belongs to the antimetabolic group of medications. This activity reviews the indications, action, and contraindications for cytarabine as a valuable agent in treating acute myeloid leukemia (and other leukemias. | Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
Reviews
There are no reviews yet.